Clinical Evaluation of Random Biopsy of Urinary Bladder in Patients with Superficial Bladder Cancer
β Scribed by Isao Taguchi; Kazuo Gohji; Isao Hara; Akinobu Gotoh; Yuji Yamada; Kazuki Yamanaka; Hiroshi Okada; Soichi Arakawa; Sadao Kamidono
- Book ID
- 108976322
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 444 KB
- Volume
- 5
- Category
- Article
- ISSN
- 0919-8172
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Several postoperative adjuvant therapeutic modalities have been adopted in attempts to reduce the recurrence rate of superficial bladder cancer. However, no definite conclusions on the effectiveness of intravesical chemoprophylaxis have been reached. A randomized clinical study on intravesical chemo
Difluoromethylornithine (DFMO) is a promising chemopreventive agent which is excreted unchanged in the urine, is active in vivo against superficial bladder cancer in animal tumor model systems, and has cytotoxic activity in viffo against superficial bladder cancer cells. Thus, DFMO may be particular